Symbols / CLOV Stock $2.42 +0.63% Clover Health Investments, Corp.

Healthcare • Healthcare Plans • United States • NMS
CLOV (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: SMA 50: SMA 200:
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Healthcare Plans
CEO Mr. Andrew Toy
Exch · Country NMS · United States
Market Cap 1.27B
Enterprise Value 1.14B
Income -85.55M
Sales 1.92B
FCF (ttm) -35.82M
Book/sh 0.59
Cash/sh 0.23
Employees 724
Insider 10d
IPO Jun 12, 2020
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E
Forward P/E 26.83
PEG
P/S 0.66
P/B 4.06
P/C
EV/EBITDA -13.35
EV/Sales 0.59
Quick Ratio 1.34
Current Ratio 1.47
Debt/Eq
LT Debt/Eq
EPS (ttm) -0.17
EPS next Y 0.09
EPS Growth
Revenue Growth 44.70%
EPS Gr Q/Q
Rev Gr Q/Q
Earnings (next) 2026-05-06
Earnings (prior) 2026-02-25
ROA -9.53%
ROE -26.33%
ROIC
Gross Margin 18.46%
Oper. Margin -10.11%
Profit Margin -4.45%
Shs Outstand 428.95M
Shs Float 405.81M
Insider Own 3.24%
Instit Own 29.81%
Short Float 9.37%
Short Ratio 6.96
Short Interest 39.12M
52W High 3.92
vs 52W High -38.39%
52W Low 1.58
vs 52W Low 52.85%
Beta 2.25
Impl. Vol. 34.09%
Rel Volume 0.14
Avg Volume 5.94M
Volume 813.93K
Target (mean) $2.82
Tgt Median $2.75
Tgt Low $2.50
Tgt High $3.20
# Analysts 3
Recom None
Prev Close $2.40
Price $2.42
Change 0.63%
About

Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It also operates Clover Assistant, a software platform for physicians to detect, identify, and manage chronic diseases. The company was founded in 2014 and is based in Wilmington, Delaware.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus Mean price target
2. Current target Latest analyst target
3. DCF / Fair value Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$2.40
Low
$2.50
High
$3.20
Mean
$2.82

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-20 main Canaccord Genuity Buy → Buy $3
2026-03-05 main Leerink Partners Market Perform → Market Perform $3
2026-01-20 main Canaccord Genuity Buy → Buy $4
2025-11-06 main Canaccord Genuity Buy → Buy $4
2025-08-07 main Canaccord Genuity Buy → Buy $4
2025-08-06 main UBS Neutral → Neutral $3
2025-03-03 main Canaccord Genuity Buy → Buy $5
2024-12-17 init Craig-Hallum — → Buy $6
2024-10-07 init UBS — → Neutral $4
2023-08-11 main Citigroup Neutral → Neutral $2
2023-03-06 main Canaccord Genuity — → Buy $3
2023-03-06 main Credit Suisse — → Underperform $1
2022-11-16 main Citigroup — → Neutral $2
2022-11-08 main SVB Leerink — → Market Perform $2
2022-08-09 main Citigroup — → Neutral $4
2022-08-09 main Credit Suisse — → Underperform $3
2022-05-10 main SVB Leerink — → Market Perform $3
2022-02-25 main SVB Leerink — → Market Perform $3
2022-02-02 init Canaccord Genuity — → Buy $6
2022-02-02 up Cowen & Co. Underperform → Market Perform $3
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-01 REYNOSO JAMIE L. Officer 159,384 $0.00 $0
2026-04-01 TOY ANDREW Chief Executive Officer 956,307 $0.00 $0
2026-04-01 PRIEST BRADY PATRICK Officer 191,261 $0.00 $0
2026-04-01 WAI CONRAD Officer 267,766 $0.00 $0
2026-04-01 SOARES KAREN Officer 382,522 $0.00 $0
2026-03-18 REYNOSO JAMIE L. Officer 5,833 $1.91 $11,141
2026-03-04 PRIEST BRADY PATRICK Officer 175,000 $2.17 $379,750
2026-01-20 REYNOSO JAMIE L. Officer 4,597 $2.58 $11,860
2026-01-07 REYNOSO JAMIE L. Officer 2,102 $2.53 $5,318
2026-01-07 GARIPALLI VIVEK Director and Beneficial Owner of more than 10% of a Class of Security 1,655,949
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
1,924.31
+40.34%
1,371.13
+8.77%
1,260.54
+14.96%
1,096.55
Operating Revenue
1,891.73
+40.66%
1,344.88
+8.83%
1,235.77
+13.91%
1,084.87
Cost Of Revenue
1,568.41
+55.85%
1,006.33
+0.17%
1,004.59
+1.16%
993.07
Reconciled Cost Of Revenue
1,568.41
+55.85%
1,006.33
+0.17%
1,004.59
+1.16%
993.07
Gross Profit
355.90
-2.44%
364.80
+42.53%
255.95
+147.35%
103.48
Operating Expense
441.43
+7.60%
410.26
-5.80%
435.52
+11.63%
390.14
Selling General And Administration
439.75
+7.53%
408.93
-7.11%
440.25
-8.74%
482.40
General And Administrative Expense
439.75
+7.53%
408.93
-7.11%
440.25
-8.74%
482.40
Salaries And Wages
225.47
-3.00%
232.45
-9.61%
257.16
-7.74%
278.73
Other Gand A
214.27
+21.41%
176.48
-3.61%
183.09
-10.11%
203.68
Other Operating Expenses
-7.24
+92.25%
-93.45
Total Expenses
2,009.84
+41.88%
1,416.59
-1.63%
1,440.11
+4.11%
1,383.22
Operating Income
-85.53
-88.14%
-45.46
+74.68%
-179.56
+37.36%
-286.66
Total Operating Income As Reported
-85.53
-86.95%
-45.75
+77.72%
-205.33
+28.37%
-286.66
EBITDA
-83.86
-86.63%
-44.94
+78.36%
-207.63
+17.62%
-252.03
Normalized EBITDA
-83.84
-89.99%
-44.13
+75.08%
-177.05
+37.98%
-285.48
Reconciled Depreciation
1.69
+26.67%
1.33
-46.95%
2.51
+111.37%
1.19
EBIT
-85.55
-84.91%
-46.27
+77.98%
-210.14
+17.01%
-253.22
Total Unusual Items
-0.02
+97.52%
-0.81
+97.37%
-30.58
-191.43%
33.44
Total Unusual Items Excluding Goodwill
-0.02
+97.52%
-0.81
+97.37%
-30.58
-191.43%
33.44
Special Income Charges
0.00
+100.00%
-0.29
+98.88%
-25.77
-210.46%
23.33
Other Special Charges
-23.33
Impairment Of Capital Assets
0.00
0.00
-100.00%
15.95
0.00
Restructuring And Mergern Acquisition
0.00
-100.00%
0.29
-97.07%
9.82
0.00
Net Income
-85.55
-98.91%
-43.01
+79.84%
-213.36
+37.17%
-339.57
Pretax Income
-85.55
-84.91%
-46.27
+77.98%
-210.15
+17.45%
-254.58
Net Non Operating Interest Income Expense
0.00
0.00
+100.00%
-0.01
+99.49%
-1.36
Interest Expense Non Operating
0.00
0.00
-100.00%
0.01
-99.49%
1.36
Net Interest Income
0.00
0.00
+100.00%
-0.01
+99.49%
-1.36
Interest Expense
0.00
0.00
-100.00%
0.01
-99.49%
1.36
Other Income Expense
-0.02
+97.52%
-0.81
+97.37%
-30.58
-191.43%
33.44
Gain On Sale Of Security
-0.02
+96.13%
-0.52
+89.26%
-4.81
-147.56%
10.12
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-85.55
-98.91%
-43.01
+79.84%
-213.36
+37.17%
-339.57
Net Income From Continuing Operation Net Minority Interest
-85.55
-84.91%
-46.27
+77.98%
-210.15
+17.45%
-254.58
Net Income From Continuing And Discontinued Operation
-85.55
-98.91%
-43.01
+79.84%
-213.36
+37.17%
-339.57
Net Income Continuous Operations
-85.55
-84.91%
-46.27
+77.98%
-210.15
+17.45%
-254.58
Net Income Discontinuous Operations
0.00
-100.00%
3.26
+201.37%
-3.21
+96.22%
-84.98
Normalized Income
-85.53
-88.14%
-45.46
+74.68%
-179.57
+37.66%
-288.03
Net Income Common Stockholders
-85.55
-98.91%
-43.01
+79.84%
-213.36
+37.17%
-339.57
Diluted EPS
-0.17
-112.50%
-0.08
+81.92%
-0.44
+37.81%
-0.71
Basic EPS
-0.17
-112.50%
-0.08
+81.92%
-0.44
+37.81%
-0.71
Basic Average Shares
511.97
+4.48%
490.02
+1.63%
482.18
+1.25%
476.24
Diluted Average Shares
511.97
+4.48%
490.02
+1.63%
482.18
+1.25%
476.24
Diluted NI Availto Com Stockholders
-85.55
-98.91%
-43.01
+79.84%
-213.36
+37.17%
-339.57
Depreciation Amortization Depletion Income Statement
1.69
+26.67%
1.33
-46.95%
2.51
+111.37%
1.19
Depreciation And Amortization In Income Statement
1.69
+26.67%
1.33
-46.95%
2.51
+111.37%
1.19
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
541.01
-6.84%
580.74
+1.76%
570.67
-29.43%
808.62
Current Assets
307.86
-10.28%
343.12
-19.83%
427.97
-31.52%
625.00
Cash Cash Equivalents And Short Term Investments
120.26
-45.72%
221.56
-6.21%
236.23
-29.43%
334.76
Cash And Cash Equivalents
78.30
-59.75%
194.54
+67.12%
116.41
+12.16%
103.79
Other Short Term Investments
41.95
+55.32%
27.01
-77.46%
119.82
-48.12%
230.97
Receivables
158.74
+71.07%
92.79
+7.60%
86.24
-48.53%
167.54
Other Receivables
158.74
+71.07%
92.79
+7.60%
86.24
-48.53%
167.54
Prepaid Assets
18.21
+38.22%
13.17
-8.63%
14.42
-20.54%
18.15
Restricted Cash
55.63
-44.65%
100.50
Assets Held For Sale Current
0.00
-100.00%
72.47
Other Current Assets
10.65
-31.75%
15.60
-16.17%
18.61
+360.35%
4.04
Total Non Current Assets
233.16
-1.88%
237.62
+66.51%
142.70
-22.29%
183.62
Net PPE
6.38
+20.31%
5.31
+4.43%
5.08
-48.03%
9.78
Gross PPE
13.98
+24.63%
11.22
+16.10%
9.66
-20.05%
12.09
Accumulated Depreciation
-7.60
-28.51%
-5.91
-29.04%
-4.58
-98.31%
-2.31
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
10.84
+34.24%
8.07
+23.88%
6.52
+37.46%
4.74
Other Properties
0.11
+0.00%
0.11
+0.00%
0.11
-97.38%
4.31
Leases
3.04
+0.00%
3.04
+0.00%
3.04
+0.00%
3.04
Goodwill And Other Intangible Assets
2.99
+0.00%
2.99
+0.00%
2.99
-85.05%
20.00
Goodwill
0.00
-100.00%
11.75
Other Intangible Assets
2.99
+0.00%
2.99
+0.00%
2.99
-63.76%
8.25
Investments And Advances
199.66
-7.59%
216.06
+78.56%
121.00
-12.39%
138.11
Other Non Current Assets
24.12
+81.90%
13.26
-2.71%
13.63
-13.39%
15.73
Total Liabilities Net Minority Interest
232.31
-3.04%
239.60
-15.72%
284.28
-37.07%
451.73
Current Liabilities
208.82
-2.20%
213.52
-18.23%
261.12
-39.49%
431.51
Payables And Accrued Expenses
205.50
-2.17%
210.05
+7.59%
195.24
-43.92%
348.11
Payables
189.46
-0.78%
190.96
+9.57%
174.28
-46.23%
324.15
Accounts Payable
36.21
+4.77%
34.56
-7.05%
37.18
+14.61%
32.45
Other Payable
153.25
-2.01%
156.40
+14.07%
137.10
-52.75%
290.14
Current Accrued Expenses
16.04
-15.99%
19.09
-8.88%
20.95
-12.57%
23.96
Current Debt And Capital Lease Obligation
1.67
-8.87%
1.83
Current Capital Lease Obligation
1.67
-8.87%
1.83
Current Deferred Liabilities
3.10
0.00
Current Deferred Revenue
3.10
0.00
Other Current Liabilities
3.32
-4.10%
3.47
-94.74%
65.88
-11.37%
74.33
Total Non Current Liabilities Net Minority Interest
23.48
-9.96%
26.08
+12.61%
23.16
+14.52%
20.23
Long Term Debt And Capital Lease Obligation
3.00
-25.66%
4.03
Long Term Debt
Long Term Capital Lease Obligation
3.00
-25.66%
4.03
Other Non Current Liabilities
23.48
-9.96%
26.08
+12.61%
23.16
+43.04%
16.19
Preferred Securities Outside Stock Equity
Stockholders Equity
308.70
-9.51%
341.14
+19.12%
286.39
-19.75%
356.89
Common Stock Equity
308.70
-9.51%
341.14
+19.12%
286.39
-19.75%
356.89
Capital Stock
0.05
+4.00%
0.05
+2.04%
0.05
+6.52%
0.05
Common Stock
0.05
+4.00%
0.05
+2.04%
0.05
+6.52%
0.05
Share Issued
552.45
+5.78%
522.28
+5.09%
496.96
+3.43%
480.47
Ordinary Shares Number
519.04
+3.08%
503.53
+2.96%
489.05
+2.23%
478.39
Treasury Shares Number
33.41
+78.17%
18.75
+137.00%
7.91
+281.75%
2.07
Additional Paid In Capital
2,682.66
+4.12%
2,576.47
+4.68%
2,461.24
+6.13%
2,319.16
Retained Earnings
-2,288.35
-3.88%
-2,202.80
-1.99%
-2,159.79
-10.96%
-1,946.43
Gains Losses Not Affecting Retained Earnings
0.53
+133.33%
-1.58
+33.16%
-2.37
+74.72%
-9.37
Treasury Stock
86.19
+178.10%
30.99
+143.47%
12.73
+95.56%
6.51
Minority Interest
0.00
0.00
Other Equity Adjustments
0.53
+133.33%
-1.58
+33.16%
-2.37
+74.72%
-9.37
Total Equity Gross Minority Interest
308.70
-9.51%
341.14
+19.12%
286.39
-19.75%
356.89
Total Capitalization
308.70
-9.51%
341.14
+19.12%
286.39
-19.75%
356.89
Working Capital
99.03
-23.59%
129.61
-22.32%
166.85
-13.77%
193.49
Invested Capital
308.70
-9.51%
341.14
+19.12%
286.39
-19.75%
356.89
Total Debt
4.66
-20.43%
5.86
Capital Lease Obligations
4.66
-20.43%
5.86
Net Tangible Assets
305.71
-9.59%
338.15
+19.32%
283.40
-15.88%
336.89
Tangible Book Value
305.71
-9.59%
338.15
+19.32%
283.40
-15.88%
336.89
Available For Sale Securities
187.09
-7.25%
201.72
+67.81%
120.21
-12.49%
137.37
Current Provisions
7.24
Derivative Product Liabilities
Dueto Related Parties Current
1.36
-12.96%
1.57
Held To Maturity Securities
12.57
-12.35%
14.34
+1708.70%
0.79
+6.87%
0.74
Investmentin Financial Assets
199.66
-7.59%
216.06
+78.56%
121.00
-12.39%
138.11
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-66.93
-292.09%
34.84
+124.09%
-144.66
+29.06%
-203.93
Cash Flow From Continuing Operating Activities
-66.93
-181.18%
82.45
+334.58%
-35.15
+88.46%
-304.60
Cash From Discontinued Operating Activities
0.00
+100.00%
-47.60
+56.53%
-109.51
-208.78%
100.67
Net Income From Continuing Operations
-85.55
-98.91%
-43.01
+79.84%
-213.36
+37.17%
-339.57
Depreciation Amortization Depletion
1.69
+26.67%
1.33
-46.95%
2.51
+111.37%
1.19
Depreciation And Amortization
1.69
+26.67%
1.33
-46.95%
2.51
+111.37%
1.19
Other Non Cash Items
-1.57
+49.21%
-3.10
+22.89%
-4.01
-172.51%
-1.47
Stock Based Compensation
103.66
-9.34%
114.33
-18.87%
140.93
-14.23%
164.31
Provisionand Write Offof Assets
0.00
0.00
+100.00%
-7.24
+92.26%
-93.52
Asset Impairment Charge
0.00
0.00
-100.00%
15.95
0.00
Operating Gains Losses
-0.96
-2691.89%
0.04
-99.23%
4.79
+114.44%
-33.18
Gain Loss On Investment Securities
-0.96
-2691.89%
0.04
-99.23%
4.79
+148.65%
-9.85
Gain Loss On Sale Of PPE
Change In Working Capital
-84.20
-754.97%
12.86
-49.17%
25.29
+1172.02%
-2.36
Change In Receivables
-65.95
-906.55%
-6.55
-237.82%
4.75
+159.21%
-8.03
Change In Prepaid Assets
-5.04
-504.74%
1.24
-66.63%
3.73
+209.17%
-3.42
Change In Payables And Accrued Expense
-1.41
+69.40%
-4.59
-349.78%
1.84
-88.81%
16.42
Change In Accrued Expense
-3.05
-54.85%
-1.97
+32.06%
-2.90
-133.03%
8.78
Change In Payable
1.65
+162.86%
-2.62
-155.29%
4.74
-37.93%
7.63
Change In Account Payable
1.65
+162.86%
-2.62
-155.29%
4.74
-37.93%
7.63
Change In Other Working Capital
-3.15
-116.30%
19.30
+6663.27%
-0.29
-127.30%
1.08
Change In Other Current Assets
-5.92
-307.61%
2.85
-67.81%
8.86
+207.93%
-8.21
Change In Other Current Liabilities
-2.74
-552.31%
0.61
-90.54%
6.40
+3254.68%
-0.20
Investing Cash Flow
4.08
+621.42%
0.56
-99.60%
140.01
+47.18%
95.13
Cash Flow From Continuing Investing Activities
4.08
+621.42%
0.56
-99.60%
140.01
+47.18%
95.13
Net PPE Purchase And Sale
-2.04
-31.30%
-1.56
-166.44%
-0.58
+86.93%
-4.47
Purchase Of PPE
-2.04
-31.30%
-1.56
-166.44%
-0.58
+86.93%
-4.47
Capital Expenditure
-2.04
-31.30%
-1.56
-166.44%
-0.58
+86.93%
-4.47
Net Investment Purchase And Sale
6.12
+188.50%
2.12
-98.49%
140.60
+21.41%
115.80
Purchase Of Investment
-205.10
-1.92%
-201.24
-14.62%
-175.57
+52.50%
-369.65
Sale Of Investment
211.22
+3.86%
203.36
-35.68%
316.16
-34.87%
485.45
Net Business Purchase And Sale
0.00
0.00
+100.00%
-16.20
Purchase Of Business
0.00
0.00
+100.00%
-16.20
Financing Cash Flow
-53.38
-207.49%
-17.36
-242.43%
-5.07
-2.18%
-4.96
Cash Flow From Continuing Financing Activities
-53.38
-207.49%
-17.36
-242.43%
-5.07
-2.18%
-4.96
Net Issuance Payments Of Debt
0.00
0.00
Issuance Of Debt
0.00
Repayment Of Debt
0.00
0.00
Long Term Debt Issuance
0.00
Long Term Debt Payments
0.00
0.00
Net Long Term Debt Issuance
0.00
0.00
Net Common Stock Issuance
-53.38
-207.49%
-17.36
-242.43%
-5.07
-2.18%
-4.96
Common Stock Payments
-55.20
-202.24%
-18.26
-193.62%
-6.22
+2.23%
-6.36
Repurchase Of Capital Stock
-55.20
-202.24%
-18.26
-193.62%
-6.22
+2.23%
-6.36
Proceeds From Stock Option Exercised
0.00
0.00
Net Other Financing Charges
-28.79
-134.93%
82.42
Changes In Cash
-116.24
-744.04%
18.05
+285.71%
-9.72
+91.46%
-113.75
Beginning Cash Position
194.54
+10.23%
176.49
-5.22%
186.21
-37.92%
299.97
End Cash Position
78.30
-59.75%
194.54
+10.23%
176.49
-5.22%
186.21
Free Cash Flow
-68.98
-307.21%
33.29
+122.92%
-145.25
+30.30%
-208.39
Interest Paid Supplemental Data
0.00
0.00
Common Stock Issuance
1.81
+101.11%
0.90
-21.57%
1.15
-17.86%
1.40
Issuance Of Capital Stock
1.81
+101.11%
0.90
-21.57%
1.15
-17.86%
1.40
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category